|
⚲
|
| Keyboard |
| Sean Stalfort | |
|---|---|
| Firm | |
| Address | c/o Verrica Pharmaceuticals Inc 44 W Gay St, Suite 400 West Chester, PA 19380 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc | 021-566413 | Director | 50.0 M of 50.0 M |
||
| Blue Marlin Therapeutics Inc | 021-561543 | Executive Officer | 0.1 M | ||
| Taysha Gene Therapies Inc | 021-490724 | Director | 150.0 M of 150.0 M |
||
| Saliogen Therapeutics Inc | 021-423901 | Director | 132.2 M of 132.2 M |
||
| Xalud Therapeutics Inc | 021-401483 | Director | 18.2 M of 30.0 M |
||
| Saliogen Therapeutics Inc | 021-389813 | Director | 20.0 M of 20.0 M |
||
| Xalud Therapeutics Inc | 021-363916 | Director | 5.0 M of 25.1 M |
||
| Tolerion Inc | 021-360181 | Director | 23.0 M of 29.8 M |
||
| Tolerion Inc | 021-359489 | Director | 20.0 M of 40.0 M |
||
| Advantagene Inc | 021-326482 | Director | 28.7 M of 28.7 M |
||
| Verrica Pharmaceuticals Inc | 021-306127 | Director | 20.0 M of 21.0 M |
||
| Verrica Pharmaceuticals Inc | 021-301519 | Director | 5.0 M of 5.0 M |
||
| Verrica Pharmaceuticals Inc | 021-253241 | Director | 2.4 M | ||